Ibex Medical Analytics Funding, Investors & Competitors

Hippocratic AI is a San Francisco-headquartered developer of large language models optimized for non-diagnostic healthcare interactions. Its platform deploys AI agents for tasks like preoperative education, discharge instructions, and chronic disease follow-ups via phone or text. Built on a multi-agent architecture with clinician oversight, the system includes an agent marketplace for specialties such as cardiology and oncology. Health systems integrate agents into workflows for patient outreach and triage support.

Komodo Health is a San Francisco-headquartered platform that maps over 500 million patient journeys by integrating claims, clinical, and pharmacy data sources into its Healthcare Map. The system leverages AI and data science to deliver real-world evidence and market insights for life sciences companies, healthcare payers, and providers. Since its founding in 2014, it serves more than 1,500 life sciences organizations including major pharmaceutical firms in therapy development and commercialization. The company maintains a presence across the United States with additional offices in New York and Boston.

Anthropic is an AI safety company developing large language models and researching methods to make artificial intelligence more reliable and steerable. Anthropic was founded in 2021 by former OpenAI researchers including Dario and Daniela Amodei. The company's flagship product is Claude, a family of AI assistants deployed across consumer applications and enterprise APIs. Research priorities center on constitutional AI, mechanistic interpretability, and alignment techniques. Major investors include Google, Spark Capital, and Salesforce Ventures.

OpenAI is an AI research and deployment company that develops large language models, including the GPT series, and consumer-facing products such as ChatGPT. Founded in 2015 as a nonprofit research lab, the organization transitioned to a capped-profit structure in 2019 to attract the capital needed for large-scale AI development. The company offers API access to its models for enterprise and developer use, alongside image generation through DALL-E and code-assistance tools. Headquartered in San Francisco, OpenAI has become one of the most prominent players in the generative AI space, backed by a multibillion-dollar investments from Microsoft, Amazon, NVIDIA, SoftBank and many more.

Founded in 2012, Snowflake is a fully managed platform that consolidates data hosted on different public clouds for centralized analytics and governance. Snowflake’s cloud-native architecture allows users to independently scale the compute and storage layers, providing customers with optimized performance at lower costs. The company’s data lake and data warehouse products support a variety of use cases, including business analytics, data engineering, and artificial intelligence. Snowflake is widely used by Fortune 2000 companies in financial services, media, and retail sectors.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier’s children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

DeepSeek is a Chinese frontier AI lab that develops open-source large language models. DeepSeek conducts research in machine learning, natural language processing and related AI applications. DeepSeek has earned global recognition by challenging the hegemony of U.S. AI incumbents (like OpenAI and Google) through technological breakthroughs in efficiency and reasoning. DeepSeek-R1: A powerful reasoning model that rivals premium Western models. Its unique capability to mimic human thought and break down mathematical or programming tasks incrementally sent shockwaves through the tech industry.DeepSeek-V3 & V4: State-of-the-art general language models capable of running incredibly fast while consuming significantly less computational power than peer models.

Cognition is a San Francisco-based applied AI lab developing end-to-end software agents that function as collaborative teammates for engineering projects. Its agents automate complex tasks to boost team efficiency and innovation through https://www.cognition.ai.

Z.ai is an advanced artificial intelligence platform known for its GLM model series, multimodal creation tools, and cost-efficient agentic coding environments like ZCode. It provides high-performance reasoning, real-time web search capabilities, and versatile utilities for building full-stack applications and data dashboards.

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

Project Prometheus is an artificial intelligence company developing AI systems for the physical economy, with applications across engineering and manufacturing in sectors such as aerospace, automotive, and computing. Founded in 2025 and headquartered in San Francisco with offices in London and Zurich, the company is co-led by Amazon founder Jeff Bezos and Vik Bajaj, a chemist and physicist formerly of Google X and co-founder of Verily. Unlike large language models that learn primarily from digital text, Prometheus focuses on AI that learns from real-world experimentation and physical trial and error, aiming to optimize design, production, and performance in industrial settings. The company launched with $6.2 billion in initial funding and subsequently closed a $10 billion round at a valuation of approximately $38 billion, with participation from investors including JPMorgan Chase and BlackRock. Its team has grown to over 120 employees, drawing talent from OpenAI, Google DeepMind, and Meta, and the company acquired agentic AI startup General Agents in 2025.

Moonshot AI is a Beijing-headquartered artificial intelligence company developing large language models like Kimi, a chatbot rivaling GPT-4 with 200K token context. Founded in 2023 by ex-Google researchers from Gemini and Bard teams, it processes Chinese-English queries via proprietary MoE architecture. Moonshot AI serves enterprise clients in search, content generation, and multimodal tasks across Asia.

Safe Superintelligence is a Palo Alto-based AI firm building systems with embedded safety protocols. Launched in 2024, the company develops risk assessment frameworks and mitigation tools to ensure secure deployment of advanced models in enterprise settings.

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company’s sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Mistral AI is a Paris-headquartered developer of open-source large language models outperforming GPT-3.5 benchmarks. The company releases models like Mistral 7B, Mixtral 8x7B with 46.7 percent MT-Bench scores, and Pixtral 12B for vision-language tasks. Enterprises deploy these via La Plateforme API supporting 80 billion parameter models for coding, translation, and summarization. Mistral AI partners with Microsoft Azure and NVIDIA for inference hardware. Founded in 2023, it serves clients in automotive and finance across Europe and the U.S.